On Wednesday, Novartis gave a more detailed look at long-awaited clinical data that the company believes will help secure a broad approval for a successor drug to its blockbuster gene therapy ...

We can do better. Together with Susan G. Komen, Novartis is proud to announce the creation and launch of the Alliance for Breast Cancer Policy. The coalition comprises more than 20 partner ...

Novartis (NVS) shareholders agreed to the board of directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting, the company announced. “With a dividend ...

A total of 1,693 shareholders were present at the meeting held in Basel, representing approximately 57.42% of the issued shares of Novartis. With a dividend increase of 6.1% to CHF 3.50 per share, ...

TOKYO -- Swiss pharmaceutical company Novartis plans to start mass production of radiopharmaceuticals, a type of next-generation cancer treatment, in Japan in 2026, Nikkei has learned. The company ...

ZURICH, March 6 (Reuters) - Novartis (NOVN.S), opens new tab is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the drug maker's ...

The cash from Novartis will help Avrobio keep the lights on for longer, pushing out its operating runway to the fourth quarter of next year — valuable flexibility in a market that remains challenging ...